The Thunderclap Headache - McGill University

The Thunderclap Headache - McGill University

The Thunderclap Headache Amy Yu, PGY-3 July 14 2010 McGill University Outline Subarachnoid Why do we care? How do we diagnose it? Then what? Migraine

hemorrhage Evaluation Treatment SAH Why do we care? Because it can kill your patient Average case fatality rate 51% 10% die before reaching the hospital 25% die within 24 hours of SAH onset 45% percent die within 30 days Because

you can do something about it 30-50% have sentinel bleed or "warning leak Sudden and severe headache preceding SAH by 6-20 days SAH Etiology Most SAHs are caused by ruptured saccular aneurysms 15-20% negative angiography 24% will have lesion on 2nd angiography

Other etiologies Trauma, AVM, vasculitides, intracranial arterial dissections, amyloid angiopathy, bleeding diatheses, and illicit drug use (cocaine and amphetamines) SAH Risk factors Cigarette smoking #1 preventable RF for SAH, more prominent in women and aneurysmal SAH

Dose-dependent, risk decline with quitting Hypertension (RR 2.5) Alcohol Moderate to heavy consumption RR 2.1 Sympathomimetic drugs Phenylpropanolamine (appetite suppressants, cold remedies), cocaine

Estrogen deficiency Antithrombotic therapy Not risk, but worsens outcome SAH Risk factors Genetic risk AD PCKD, EDS, other CT disease Worrisome

family history Two affected 1st degree relatives One affected 1st degree relatives: need to screen ~300 ppl to prevent one fatal SAH 1-2% Prevalence of intracranial saccular aneurysm (up to 5% radiographic & autopsy) 3-25 per 100,000 Aneurysmal SAH SAH Presentation Aneurysm rupture rapid release of blood in CSF, rapid increase in ICP

Bleeding last a few seconds Can recur, usually within 1st 24 hours Most common symptoms Onset of sudden, severe headache, worst headache of my life Lateralized in 30% (usually ipsilateral to aneurysm) May have: brief LOC, seizure, nausea, vomiting, meningismus

POP QUIZ 37 y.o. sudden onset severe h/a while weight-lifting. Examination normal. Now h/a free with maxeran. What is the next step in management? a) Reassurance and d/c home with f/u b) CT head and if normal d/c home c) CT head, Lumbar puncture d) Admission for observation POP QUIZ 37 y.o. sudden onset severe h/a while weight-lifting. Examination normal. Now h/a free with maxeran. What is the next step in management? a) Reassurance and d/c home with f/u b) CT head and if normal d/c home c) CT head, Lumbar puncture d) Admission for observation

SAH Presentation Prospective study of sentinel headache in aneurysmal SAH. Linn FH et al. Lancet 1994;344(8922):590-3 148 sudden severe h/a patients for evaluation of SAH 25% was diagnosed with SAH 12% with headache as the only symptom Physical

exertion May be an acute trigger for SAH Moderate or greater exertion in the two hours prior to SAH (OR 2.7, 95% CI 1.6-4.6) SAH Physical examination Retinal hemorrhage Vitreous hemorrhage (Tersons syndrome) Meningismus Decreased level of consciousness Focal neuro signs (CN III palsy, CN VI palsy, bilateral leg weakness) POP QUIZ Why are the following signs seen in aneurysmal SAH?

a) CN III palsy b) CN VI palsy c) Bilateral leg weakness POP QUIZ Why are the following signs seen in aneurysmal SAH? a) CN III palsy PCoA, SCA b) CN VI palsy Raised ICP c) Bilateral leg weakness ACA involvement SAH CT head, non-contrast Sensitivity

98% in first 12 hours 93% in first 24 hours 80% at 72 hours 70% at 5 days 50% after 7 days SAH Lumbar puncture Classic finding Elevated opening pressure Elevated RBC count that does not diminish between Tube #1 to #4

Xanthochromia post centrifugation POP QUIZ LP done for first thunderclap headache, CT head normal Tube #1 132 RBC, Tube #4 19 RBC a) What is your diagnosis? b) What further information would you like? c) What is the next step? Distinguishing Traumatic Lumbar Puncture From True SAH Kaushal, Edlow J of Emerg Med, Vol 23, No 1, pp. 6774, 2002 CSF

Red cell count RBC disappears over days to weeks No standard criterion for how many RBCs in the CSF can definitely diagnose a SAH Three-tube test No absolute differences associated with diagnosis, unless the count in final tube approaches zero Cannot assess concurrent SAH and traumatic tap Consider letting out extra CSF in the 3rd tube

SAH vs. Traumatic tap Xanthochromia Hemoglobin degradation appears 4-10 hours from bleed, may last for > 2 weeks Needs immediate centrifugation and analysis Visual inspection very poor specificity Need spectrophotometry, but unavailable at most centres Sensitive, but non-specific

SAH vs. Traumatic tap Differential of xanthochromia High CSF protein Jaundice Carotene addiction Meningitis Severe degenerative disc disease SAH vs. Traumatic tap

Opening pressure Other tests Can help R/O other conditions (IIH, CSVT) Not elevated in traumatic tap, is elevated in 60% of SAH

Abbrescia KL, The effect of lower-extremity position on cerebrospinal fluid pressures, Acad Emerg Med. 2001 Jan;8(1):8-12. Positioning of the legs lead to 1cmH2O difference CSF D-dimer CSF Bilirubin Requires further validation Repeat LP at higher interspace Clot formation You diagnose SAH, now what? Consult neurosurgery and neuroradiology CTA and MRA

Non-invasive Useful for screening and surgical planning Sensitive at identifying aneurysms >3-5mm CTA 83-98% Pitfalls in SAH evaluation Be alert and think about SAH when faced with acute, severe headache Understand the limitations of CT head If you think about doing an LP, you should probably do it CTA or MRA are not diagnostic tests for SAH Remember that 2-5% of the population may have

an unruptured aneurysm DDx of thunderclap headache Other vascular disease (AVM, dissection) Intracerebral hemorrhage Migraine headache Tension headache CVST Pituitary apoplexy CSF hypovolemia syndrome Syncope Part II: Migraine management Migraine epidemiology Migraine

prevalence 18% female 6% male Highest among 25-55 year olds International classification of headache disorders (2004) Migraine without aura A.At least 5 attacks fulfilling criteria B-D B.Headache attacks lasting 4-72 h (untreated or unsuccessfully treated)

C.Headache has 2 of the following characteristics: 1. unilateral location 2. pulsating quality 3. moderate or severe pain intensity 4. aggravation by or causing avoidance of routine physical activity (eg, walking, climbing stairs) D.During headache 1 of the following: 1. nausea and/or vomiting 2. photophobia and phonophobia E.Not attributed to another disorder Typical aura w/ migraine h/a A. At least 2 attacks fulfilling criteria BD B. Aura consisting of 1 of the following, but no motor weakness 1. Fully reversible visual sxs (positive and/or negative features) 2. Fully reversible sensory sxs (positive and/or negative features) 3. Fully reversible dysphasic speech disturbance

C. 2 of the following 1. Homonymous visual sxs and/or unilateral sensory sxs 2. At least 1 aura symptom develops gradually over 5 min and/ or different aura symptoms occur in succession over 5 min 3. Each symptom lasts 5 and 60 min D.H/A fulfilling criteria B-D for Migraine without aura begins during the aura or follows aura within 60 min E. Not attributed to another disorder Migraine with aura Typical aura with migraine headache Typical aura with non-migraine headache Typical aura without headache Familial hemiplegic migraine (FHM) Sporadic hemiplegic migraine Basilar-type migraine

The rational clinical examination series Does This Patient With Headache Have a Migraine or Need Neuroimaging? Michael E. Detsky et al. JAMA, September 13, 2006, Vol 296, No. 10 POUNDing Pulsatile quality duration of 4-72 hOurs Unilateral location Nausea or vomiting Disabling intensity Yes to 4 out of 5, LR 24 of definite migraine

versus non-migrainous headache Yes to 3 out of 5, LR 3.5 Yes to 1-2 out of 5, LR 0.41 Individual variables 4 most predictive variables distinguishing migraine from tension-type headache Nausea LR 19 Photophobia LR 5.8 Phonophobia LR 5.2 Exacerbation by physical activity LR 3.7

Does this patient need neuroimaging? Variable 1% in chronic headache 43% in thunderclap headache Rule prevalence of intracranial pathology

out red flags Cancer or HIV Sudden onset of symptoms Onset after age 50 years Accelerating pattern Systemic illness (fever, stiff neck, rash) Focal neurologic signs and symptoms Nonspecific treatment NSAIDs ASA Acetaminophen Baclofen Antihistamine Opioids Combinations

ASA and Acetaminophen ASA/Amphetamine/Caffeine (Excedrin) ASA/Butalbital/Caffeine (Fiorinal) Acetaminophen/Codeine (Empracet) Nonspecific treatment NSAIDs ASA 1gm IV is used in Europe for acute migraine

1gm effervescent ASA (Alka-Seltzer) Avoid Opioids Ensure adequate trial, e.g. Advil Gel caps 600mg at onset of headache May reverse central sensitization in migraine Significant side effect (nausea, sedation, etc.) May worsen central sensitization

Avoid Butalbital (Fiorinal) No benefit shown High risk of habituation and dependency Aspirin with or w/o antiemetic for acute migraine h/a in adults Kirthi V et al. Cochrane Database Syst Rev. 2010 Apr 14;4:CD008041 ASA 900mg or 1000mg superior to placebo

NNTs 8.1 (2-hr pain-free), 4.9 (2-hr h/a relief), 6.6 (24-hr h/a relief) ASA reduces N/V, photo-, phonophobia Metoclopramide significantly further reduces N/V Sumatriptan 100 mg was better only for 2-hour pain-free Adverse events with ASA Mostly mild and transient Slightly more often than placebo Less common than Sumatriptan 100mg

Specific Tx Triptans 3 main mechanisms of action Cranial vasoconstriction Peripheral trigeminal inhibition Inhibition of transmission through second order neurons of the trigeminocervical complex Oral triptans in acute migraine treatment: a meta-analysis of 53 trials Michel D Ferrari et al. Lancet 2001; 358: 166875 Collected raw patient data of 53 double-blind,

randomised, controlled, clinical trials of oral triptans in migraine (12 unpublished) Summarized estimates across studies for important efficacy and tolerability parameters Rizatriptan, Eletriptan, and Almotriptan provide the highest likelihood of consistent success Oral triptans in acute migraine treatment: a meta-analysis of 53 trials

Rizatriptan 10 mg (Maxalt) Consistent and rapid freedom from pain is desired Eletriptan 80mg (Relpax) High efficacy and low recurrence, lower tolerability Almotriptan 12.5mg (Axert, Almogran) High tolerability and good efficacy Sumatriptan 50mg and 100mg (Imitrex, Imigran) Good efficacy and tolerability Longest clinical experience Zolmitriptan 2.5mg and 5mg (Zomig, AscoTop, Zomigon) No specific advantages nor flaws Naratriptan 2.5mg (Amerge, Naramig) Good tolerability Slower onset of improvement (useful in mild or moderate migraine)

Frovatriptan (Frova) Lack of data Triptans Should be used if >10 days 50% disability in 3 mths Administered as early as possible after onset of h/a Safe medications in patients without cardiovascular disease or major vascular RF No clinically important differences in coronary

vasoconstriction effects No triptan is demonstrably safer than the others Choice dependent on patient characteristics and preferences Individual responses to a triptan cannot be predicted Specifc Tx Ergots Vasoconstriction Adrenergic receptors 5-HT receptors Norepinephrine receptors (venoconstrictors) Two

main Ergots Ergotamine (ET), more potent vasoconstrictor by stimulating Superior to placebo, inferior to PO Sumatriptan 100mg Dihydroergotamine (DHE) Also inferior to Sumatriptan, but recurrence rate lower Ergotamine

Oral bioavailability is <1% Oral ET is appropriate for slowly evolving migraine without early-onset nausea 1st pass hepatic metabolism Rectal suppository: better plasma level, less nausea One 1-mg tablet at the start of an attack Maximum total dose of 6 mg per attack

Maximum 2 days per week with an interval of at least 4 days Avoiding habituation, rebound, and daily headache Dihydroergotamine Worse Incomplete passage through GI mucosa Hepatic 1st pass metabolism 40% bioavailability intranasally Peak

oral bioavailability than ET plasma level IV 1-2 minutes IM 24 minutes IN 30-60 minutes Advantages Fewer side-effects Habituation is rare Once h/a relief is established, recurrence is low

Dihydroergotamine IN DHE 1 spray (0.5mg) into each nostril at first sign of migraine, can be repeated in 15 minutes (2mg in 4 sprays) Relatively low clinical efficacy High frequency of prolonged nasal stuffiness SC and IM DHE is equivalent DHE 1mg SC/IM, can be repeated in 60 minutes Patients are advised to mix DHE with 0.25-0.50 mL of 1% to 2% lidocaine to reduce injection-site burning

Maximum 4mg per attack, 21mg per week Ergots summary Do not mix Ergots or with triptans Do titrate dose to minimize side effects (nausea) Recognize ET is highly associated with medication overuse headache Recognize Ergots are not clearly superior to the triptans (except in the case of IV DHE) and can be less convenient to the patient What to do in the ER? IV Can be given with Diphenhydramine IV

IV Dexamethasone 10-25mg Can reduce h/a recurrence Consider Prednisone for a few days with rapid taper (e.g. Prednisone 50mg x3d, 40mg x3d, etc.) IV Metoclopramide or prochlorperazine 10 mg DHE 1 mg + Metoclopramide 10 mg

Do not mix triptan or other ergots on same day Avoid in patients with vascular disease SQ 6mg Sumatriptan Avoid in vascular disease, but can be used as a step-up to oral Triptan Other Tx to consider in the ER NSAIDs Advil Ketorolac 30mg IV, 60mg IM

Magnesium 1gm IV Good for patients with aura ASA Medication overuse headache Abortive agents should be used 2 d/week DHE and Naproxen are less likely to cause MOH ICHD2 revised criteria for MOH A. Headache present on 15 days a month B. Regular overuse for >3 mths of 1 acute/symptomatic tx drugs 1. Ergotamine, triptans, opioids, or combination analgesic medications on 10 days a month for >3

mths 2. Simple analgesics or any combination of ergotamine, triptans, analgesic opioids on 15 days a month for >3 mths without overuse of any single class alone C. Headache has developed or markedly worsened during medication overuse If too much barbiturate or codeine is on board, patient is treated with pheno 15mg tid x 3d, bid x 3d, qd x 3d During these first 3 weeks nortryptiline is begun and

patient is allowed to continue with usual symptomatic RX FU at 8-10 weeks from Day 1 35 mg W-3 1) DHE 0.5mg bid x 2 weeks, 0.5mg qd x 2 weeks + DHE as rescue Rx OR 25 mg W-2

10 mg W-1 2) Pred. 60 mg qd x3d, 50mg qd x 3d, OR 3) Naproxen 500mg bid for 2 weeks. Day 1 Pre-detoxification Detoxification STOP all symptomatic Rx Rescue medications as per patient specifics

Michel Aub md Thank you for your attention!

Recently Viewed Presentations

  • Exch Rate Systems - NYU

    Exch Rate Systems - NYU

    Westpac Bond Financing Goals Diversification - Currency - Retail and wholesale markets - Debt product types and maturity term - Debt investor types and location Flexibility Reduce cost and volatility Global debt presence and performance Westpac Ratings For senior unsecured...
  • Business Priorities Presentation - download.microsoft.com

    Business Priorities Presentation - download.microsoft.com

    Business Priorities Presentation. Click to edit Master title style. Click to edit Master subtitle style ... Business Capabilities. Summary and Next Steps. Demonstration. 11/22/2012 12:03 PM. Business Context . 70 percent of projects fail to meet schedule, cost, and quality...
  • The Structure of Sport for People with Disabilities in South ...

    The Structure of Sport for People with Disabilities in South ...

    DISABILITY SPORT SOUTH AFRICA ... and SRSA to include disability as part of "Transformation Charter" SA Games provincial academies Development in SCSA Zone VI: will be working with ASCOD Zone VI MASS PARTICIPATION Rural development project funded by Transnet in...
  • Characteristics of Qualitative Research

    Characteristics of Qualitative Research

    Characteristics of Qualitative Research EDRS 6301-05 Dr. Kielborn Summer 2001 Qualitative Research is an umbrella covering several forms of inquiry that help us understand and explain the meaning of social phenomena with as little disruption to the natural setting as...
  • Slajd 1

    Slajd 1

    Już wiele lat temu Peter Drucker lansował tezę, iż kultura zjada strategięna śniadanie. A przecież kultura to ludzie i relacje, które budują, ich energia, zaangażowanie i kompetencje. Oczywistym jest, że postawy i kompetencje pracowników wyznaczają granice gotowości organizacji do zrealizowania...
  • Icebreaker

    Icebreaker

    According to Echevarria, Vogt, and Short (2000), many ELLs need to learn a variety of strategies that fall into three categories: metacognitive, cognitive, and social/affective. They referenced Chamot and O'Malley's CALLA Handbook as a great resource for teaching English language...
  • Standardisation : current and future work at CEN

    Standardisation : current and future work at CEN

    Enprotex conference - Henk Vanhoutte ... 509 (protective textiles and personal protective clothing and equipment) Accepted on 9/11/2012 + installation of CEN-CLC BT WG 8. Final report submitted to EU Commission 02/2014 ... Pre-standardisation research e.g. Horizon 2020 calls (in...
  • Chapter 14

    Chapter 14

    Darwin and Wallace's theory rests on four postulates. Postulate 4: Individuals with advantageous traits survive longest and leave the most offspring, a process known as . natural selection. In the competition to survive and reproduce, winners are determined not by...